Cytokinetics, Incorporated (CYTK)

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $7.14 billion as of April 23, 2024. Its market cap has increased by 108.75% in one year.

• Market Cap: 7.14B
• Enterprise Value: 7.07B
• 1-Year Change: 108.75%
• Ranking: #1010
• Category: Mid-Cap
• Stock Price: $68.20

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $7.14B, an increase of 1,602.20%. That is a compound annual growth rate of 15.24%.

Market Cap History

Date	Market Cap	% Change
Apr 19, 2024	6.96B	0.82%
Apr 18, 2024	6.90B	-1.37%
Apr 17, 2024	7.00B	-1.55%
Apr 16, 2024	7.11B	1.47%
Apr 15, 2024	7.00B	-4.97%
Apr 12, 2024	7.37B	-2.23%
Apr 11, 2024	7.54B	-1.57%
Apr 10, 2024	7.66B	-0.92%
Apr 9, 2024	7.73B	1.16%
Apr 8, 2024	7.64B	2.03%
Apr 5, 2024	7.49B	5.10%
Apr 4, 2024	7.13B	-2.45%
Apr 3, 2024	7.31B	-0.07%
Apr 2, 2024	7.31B	-2.81%
Apr 1, 2024	7.52B	4.15%
Mar 28, 2024	7.22B	-1.82%
Mar 27, 2024	7.36B	0.37%
Mar 26, 2024	7.33B	3.52%
Mar 25, 2024	7.08B	1.94%
Mar 22, 2024	6.94B	2.11%
Mar 21, 2024	6.80B	-1.97%
Mar 20, 2024	6.94B	-0.34%
Mar 19, 2024	6.96B	6.02%
Mar 18, 2024	6.57B	-2.21%
Mar 15, 2024	6.71B	2.26%

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Bio-Rad Laboratories	7.93B
Encompass Health	7.93B
Penumbra	7.85B
Cerevel Therapeutics Holdings	7.66B
Masimo	7.13B
Intra-Cellular Therapies	7.01B
HealthEquity	6.97B
Inspire Medical Systems	6.94B